Screener
Avalo Therapeutics AVTX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Avalo Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Avalo Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001534120-26-000049
FAQ
- What is Avalo Therapeutics's operating margin?
- Avalo Therapeutics (AVTX) reported operating margin of -15,536.1% in Q4 2024.
- How has Avalo Therapeutics's operating margin changed year-over-year?
- Avalo Therapeutics's operating margin decreased by 993.5% year-over-year, from -1,420.8% to -15,536.1%.
- What is the long-term trend for Avalo Therapeutics's operating margin?
- Over 4 years (2020 to 2024), Avalo Therapeutics's operating margin has grown at a 94.4% compound annual growth rate (CAGR), from -1,087.2% to -15,536.1%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Avalo Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude